Africa: First Malaria Drug for Newborns Gets Who Approval

The World Health Organization (WHO) approved the first malaria treatment designed for newborns and very young infants on April 24, 2026. The medicine, artemether-lumefantrine, is intended for babies weighing between two and five kilograms, allowing for more appropriate treatment. This approval aims to close a care gap, especially in Africa, where around 30 million babies are born each year in malaria-affected areas.